Correlation of the CD4+CD25high T-regulatory cells in recipients and their corresponding donors to acute GVHD

Transplant International

Volumn 20, Issue 5, 2007, Pages 440-446

  Zhai, Zhimin ^a   Sun, Zimin ^b   Li, Qing ^a   Zhang, Aimei ^a   Liu, Huilan ^b   Xu, Jingwei ^a   Xu, Xiucai ^a   Geng, Liangquan ^b   Harris, David ^c   Hu, Shilian ^a   Wang, Yiping ^c  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Acute graft versus host disease; Allogeneic hematopoietic stem cell transplant; CD4+CD25high T cells; Regulatory

Indexed keywords

BUSULFAN; CD4 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ALPHA; PREDNISONE; TRANSCRIPTION FACTOR FOXP3; FORKHEAD TRANSCRIPTION FACTOR; FOXP3 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; MALE; ORGAN DONOR; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; T LYMPHOCYTE SUBPOPULATION; ADOLESCENT; CD4+ T LYMPHOCYTE; DONOR; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; METABOLISM; MIDDLE AGED;

ADOLESCENT; ADULT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MIDDLE AGED; TISSUE DONORS;

EID: 34047215247     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00462.x     Document Type: Article

References (21)

1. Przepiorka D, Smith TL, Folloder J, et al. Risk factors for acute graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 1999; 94: 1465.
2. Przepiorka D, Anderlini P, Saliba R, et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation. Blood 2001; 98: 1695.
3. Iwasaki T. Recent advances in the treatment of graft-versus-host disease. Clin Med Res 2004; 2: 243.
4. + selected blood cells from HLA-identical siblings. Blood 2002; 100: 724.
5. Zaucha JM, Gooley T, Bensinger WI, et al. CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling transplantation. Blood 2001; 98: 3221.
6. Sakaguchi S, Sakaguchi N, Asano M, et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151.
7. + regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med 2002; 196: 389.
8. + immunoregulatory T-cells of donor origin suppress alloreactivity after BMT. Biol Blood Marrow Transplant 2002; 8: 525.
9. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002; 99: 3493.
10. + immunoregulatory T cells: new therapeutics for graft-versus-host disease. J Exp Med 2002; 196: 401.
11. Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003; 3: 199.
12. + regulatory t cells after infusion to prevent donor lymphocyte infusion-induced lethal acute graft-versus-host disease. Biol Blood Marrow Transplant 2004; 10: 748.
13. + T cells with graft-versus-host disease after donor lymphocyte infusions. Haematologica 2005; 90: 1389.
14. Hess AD. Modulation of graft-versus-host disease: role of regulatory T lymphocytes. Biol Blood Marrow Transplant 2006; 12: 13.
15. high regulatory cells in human peripheral blood. J Immunol 2001; 167: 1245.
16. + regulatory T cells. Semin Immunol 2004; 16: 89.
17. + regulatory T cells at the single-cell level. Eur J Immunol 2005; 35: 1681.
18. + regulatory T cells in cancer patients. Blood 2006; 107: 2409.
19. Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825.
20. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor FoxP3. Science 2003; 299: 1057.
21. Lee SJ, Zahrieh D, Agura E, et al. Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial. Blood 2004; 104: 1559.